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Abstract
Background: Papillomaviruses (PVs) are a group of small, non-encapsulated, species-specific DNA viruses that have
been detected in a variety of mammalian and avian species including humans, canines and felines. PVs cause
lesions in the skin and mucous membranes of the host and after persistent infection, a subset of PVs can cause
tumors such as cervical malignancies and head and neck squamous cell carcinoma in humans. PVs from several
species have been isolated and their genomes have been sequenced, thereby increasing our understanding of the
mechanism of viral oncogenesis and allowing for the development of molecular assays for the detection of PV
infection. In humans, molecular testing for PV DNA is used to identify patients with persistent infections at risk for
developing cervical cancer. In felids, PVs have been isolated and sequenced from oral papillomatous lesions of
several wild species including bobcats, Asian lions and snow leopards. Since a number of wild felids are
endangered, PV associated disease is a concern and there is a need for molecular tools that can be used to further
study papillomavirus in these species.
Results: We used the sequence of the snow leopard papillomavirus UuPV1 to develop a PCR strategy to amplify
viral DNA from samples obtained from captive animals. We designed primer pairs that flank the E6 and E7 viral
oncogenes and amplify two DNA fragments encompassing these genes. We detected viral DNA for E6 and E7 in
genomic DNA isolated from saliva, but not in paired blood samples from snow leopards. We verified the identity of
these PCR products by restriction digest and DNA sequencing. The sequences of the PCR products were 100%
identical to the published UuPV1 genome sequence.
Conclusions: We developed a PCR assay to detect papillomavirus in snow leopards and amplified viral DNA
encompassing the E6 and E7 oncogenes specifically in the saliva of animals. This assay could be utilized for the
molecular investigation of papillomavirus in snow leopards using saliva, thereby allowing the detection of the virus
in the anatomical site where oral papillomatous lesions develop during later stages of infection and disease
development.
Background
Papillomaviruses (PVs) are a group of small, non-encap-
sulated epitheliotropic DNA viruses. PVs infect basal
keratinocytes and cause benign proliferative lesions,
termed papillomas, on the surface of cutaneous and
mucosal tissues [1]. A subset of PVs are associated with
the development of epithelial malignancies, such as cer-
vical carcinomas, oral squamous cell carcinomas
(OSCCs) and head and neck squamous cell carcinomas
(HNSCCs) in humans [2,3]. The genomes of PVs are
circular and double-stranded and contain up to 8 viral
genes that are classified as early (E) or late (L) based on
their temporal pattern of expression. Early genes encode
regulatory proteins that function in viral replication (E1
and E2), viral shedding (E4), or transformation (E5, E6
and E7) [4], whereas late genes (L1 and L2) encode viral
capsid proteins (Figure 1a) [1,5]. PVs are strictly spe-
cies-specific and have been identified in a wide variety
of vertebrates, including mammals, birds and recently
reptiles [6,7]. Genome sequencing of several PVs and
nucleotide sequence comparisons led to the develop-
ment of a PV classification scheme based on L1
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sequence identity and helped elucidate the evolutionary
relationships among PVs isolated from a variety of spe-
cies [7-9].
Due to their known association with human neopla-
sias, human papillomaviruses (HPVs) have been exten-
sively studied, thereby increasing our understanding of
the molecular mechanisms of viral oncogenesis and
revealing additional factors that contribute to the devel-
opment of malignancies. The finding that immune-defi-
cient (HIV positive) or immune-suppressed (renal
allograft recipients) individuals harbor higher numbers
of high-risk PVs underscores the importance of immune
function in the reactivation of latent infection and possi-
bly in HPV induced oncogenesis [10-12].
Feline-specific PVs belong to the lambda-papilloma-
virus genus and consist of mucosal and cutaneous types
[8]. In the domestic cat (Felis domesticus), PV infection
has been associated with a number of skin lesions such
as squamous cell carcinoma, bowenoid in-situ carci-
noma, viral plaques and sarcoids [13-16]. PV associated
disease is of particular interest in wild endangered felids,
where these viruses have been isolated from oral papillo-
matous lesions in the Florida panther (Puma concolor
coryi; PcPV1), bobcat (Lynx rufus; LrPV1), Asian lion
(Panthera leo persica; PlpPV1), snow leopard (Uncia
uncia; UuPV1) and the clouded leopard (Neofelis nebu-
losa) [9]. Sequencing and nucleotide comparisons of the
LrPV1, PcPV1, PlpPV1 and UuPV1 genomes provided
insight into their genomic organization, their evolution-
ary relationships and the mechanism of PV-host co-spe-
ciation [9]. Sequence comparisons of UuPV1 genes to
those of PVs in the alpha and beta genera revealed that
UuPV1 is more similar to beta-PVs (for example HPV-
5) which are associated with latent infections that
UuPV1
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Figure 1 Snow leopard PV1 genomic map and PCR strategy for detection of viral DNA. (a) Schematic representation of the linear Uu PV1
genome. The numbers indicate the genomic nucleotide positions. The individual open reading frames (ORFs) of the early (E) and late (L)
genomic regions are depicted as shaded arrows, and are color-coded according to the known function of the corresponding gene product. The
two cis-regulatory regions are depicted as open rectangles and consist of the upstream regulatory region (URR) and the second non-coding
region (NCR2). (b) Schematic representation of the genomic targets for PCR-based detection of viral DNA. The primers used for amplification of
the E6 and E7 genes are depicted as arrows, and the resulting amplification products as shaded rectangles. The size of each amplification
product is indicated.
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become reactivated under immunosuppression, than to
high-risk alpha PVs (for example HPV-16), which are
associated with malignancies [9].
Until recently, diagnosis of PV infection in snow leo-
pards and other wild felids has depended upon observa-
tion and histopathology of papillomatous lesions. Oral
papillomas in snow leopards are commonly seen under
the tongue and appear as small, pale nodules (Figure 2).
Very little is known about snow leopard immune
responses to PV infection, and relatively few molecular
tools are available to facilitate their study. Interpretation
of serological tests for papillomavirus antibodies can be
problematic. As with HPV infections, positive antibody
tests in snow leopards probably indicate exposure but
not necessarily current infection; PV antibodies may be
present for several months after the virus has been
cleared. False negative results are also possible because
seroconversion to the major coat protein, L1, may be
delayed for as much as 18 months after initiation of per-
sistent infections, or may not occur at all [17,18].
Epithelial infections with PVs are rarely accompanied by
inflammation, the viruses are non-lytic, viral capsid pro-
teins are differentially expressed in keratinocytes and at
very low levels in less mature cells, and the basal lamina
of the epithelium remains intact, effectively allowing
PVs to replicate without stimulating innate or adaptive
immune responses [18,19]. Additionally, PVs can evade
immune responses by establishing latent persistent
infections, integrating into the host cell genome, or initi-
ating a multitude of other defense mechanisms [18,20].
For endangered captive species such as the snow leo-
pard, immune function is an important trait. In order to
better understand how individual variation in snow leo-
pard immune function relates to papillomavirus infec-
tion, appropriate molecular tools must be developed to
study UuPV1 infection and its impact on the health and
survival of endangered felids. In the current study, we
report the development of a PCR-based assay that
detects the E6 and E7 viral oncogenes in the saliva of
snow leopards. This assay can be utilized as a novel
molecular tool to investigate the mechanisms underlying
infection and the development and progression of PV
induced disease in this endangered species.
Results
Design of a PCR strategy to amplify papillomavirus DNA
We used the published genome sequence of UuPV1
(Figure 1a) [9] to design PCR primers that amplify viral
DNA (Figure 1b). The E6 and E7 genes present ideal
targets for viral DNA detection for a number of reasons.
First, E6 and E7 are the key genes involved in the inter-
action of papillomavirus with host cell cycle pathways
and are also the target of PCR-based assays that detect
HPV-16 DNA in head and neck squamous cell carci-
noma (HNSCC) [21], suggesting that E6 and E7 can be
successfully amplified from clinical samples. Addition-
ally, even in cases when PV integrates into the host gen-
ome and a number of viral genes are lost, E6 and E7
may be the only genes that remain intact [20]. There-
fore, a PCR strategy focusing on E6 and E7 maximizes
the probability of identifying viral DNA in a variety of
snow leopard specimens corresponding to different
stages of disease progression. We designed two sets of
primers that amplify the full-length E6 and E7 genes as
two separate PCR products (Figure 1b). The two primer
pairs are positioned such that the E6 and E7 PCR pro-
ducts overlap by 95 nucleotides, which allows us to con-
firm DNA sequence information from two independent
PCR products as an additional internal control. The E6
primers anneal at genomic positions 12 (left primer)
and 705 (right primer), and amplify a 694-bp fragment
encompassing the entire E6 coding region (which spans
genomic positions 31-447), and the first 267 bp of the
E7 gene (located at genomic positions 444-728). The E7
primers anneal at genomic positions 327 (left primer)
and 800 (right primer) and produce a 472-bp fragment,
that contains the last 120 bp of the E6 gene and the
entire E7 coding region.
PCR amplification of viral DNA from snow leopard saliva
Because papillomatous lesions occur within the snow
leopard oral cavity [9,22], we wanted to determine
whether saliva represents an appropriate biological spe-
cimen for the detection of papillomavirus DNA in
Figure 2 Oral papillomatous lesions in a snow leopard. The pale
nodules on the bottom of the tongue are papillomas and are
indicated by the black circle. The papillomatous lesions are arranged
in a ring. This circular arrangement is likely the result of an earlier
biopsy in this animal. During the biopsy, viral particles seeded the
surrounding skin and caused additional papillomas to form in a
circle around the original site of ablation.
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asymptomatic animals. Additionally, since saliva collec-
tion can be performed in a non-invasive manner, beha-
vioral modification techniques can be used to train
animals to calmly accept an oral swab without the need
for chemical restraint. In this fashion, we were able to
obtain saliva samples from snow leopards in their enclo-
sure, thus minimizing anxiety to the animals and with-
out introducing them into stress-provoking situations
(Figure 3a). This is particularly important for captive
species that are not routinely subjected to chemical
restraint, and are only anesthetized for scheduled physi-
cal exams every year or every two or three years. In
these cases, saliva represents a more easily and fre-
quently accessible biological specimen than blood.
A positive result in a PCR-based assay would indicate
presence of the virus in the oral cavity of the animal, as
opposed to a serological test which can indicate expo-
sure, but not necessarily current infection. We obtained
matched saliva and blood samples from three snow leo-
pards that did not have oral papillomatous lesions: two
adult females that were approximately 18 years old (SL
1 and SL 3), and a 7-week old female cub (SL 2; Figure
3b). We used the E6 and E7 primer pairs in amplifica-
tion reactions using DNA purified from the paired
blood and saliva samples (Figure 4a and 4b). We
obtained amplification products of the expected size for
both E6 (Figure 4a, lanes 3 and 7) and E7 (Figure 4b,
lanes 3 and 7) using saliva from the two adult snow leo-
pards (SL 1 and SL 3) but not from the cub (Figure 4a,
lane 5; Figure 4b lane 5). Additionally, we were unable
to detect viral DNA for E6 and E7 in DNA purified
from the matched blood samples of the two adult snow
leopards (Figure 4a, lanes 2 and 6; Figure 4b, lanes 2
and 6). This was not due to the absence of DNA in any
of the saliva or blood samples, since we successfully
amplified a 503-bp product corresponding to the coding
Figure 3 Collection of saliva samples from a captive snow leopard using the Oragene •ANIMAL kit. (a) Saliva was collected from a 2-year
old female snow leopard in its enclosure using the Oragene •ANIMAL kit. The sample was collected by the handler of the animal through the
cage using two Oragene •ANIMAL sponges, and was stabilized in the Oragene •ANIMAL solution. (b) Saliva collection using the Oragene
•ANIMAL kit from a 7-week old female cub during a routine veterinary exam.
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region of the snow leopard transferrin receptor (TfR) as
a positive control (Figure 4c, lanes 1-6). Additional sal-
iva samples obtained from two snow leopards at another
facility were negative for E6 and E7 DNA (data not
shown).
Validation of the E6 and E7 PCR products by restriction
digest and DNA sequencing
Since restriction digests provide a fast and cost-effec-
tive method to rapidly screen PCR products, we devel-
oped a restriction endonuclease digestion assay of the
amplification products to confirm that they correspond
to the E6 and E7 viral genes. The restriction enzyme
TaqI cleaves the E6 PCR product twice, producing
three fragments of 288, 279 and 127 bp (Figure 5a, top
panel). The E7 PCR product contains three RsaI
restriction sites, yielding two large fragments (263 and
144 bp) and two smaller fragments (36 and 29 bp; Fig-
ure 5b, top panel). Digestion of the E6 PCR products
Figure 4 Amplification of the UuPV1 E6 and E7 genes from
paired saliva and blood samples. 50 ng of genomic DNA isolated
using the Oragene•ANIMAL kit (An), or paired blood samples (Bl)
from three snow leopards (SL 1, 2 and 3) were used for PCR
amplification. Amplification products were resolved by agarose gel
electrophoresis and visualized by staining with SYBR® Green. (a)
Amplification of a 694-bp fragment encompassing the E6 viral
oncogene from saliva (lanes 3, 5 and 7) and blood (lanes 2, 4 and
6). An amplification control with no DNA was performed in parallel
(lane 1). (b) Amplification of a 472-bp DNA fragment encompassing
the E7 viral oncogene from paired saliva (lanes 3, 5 and 7) and
blood samples (Bl; lanes 2, 4 and 6). Lane 1 shows a control
amplification reaction with no DNA. (c) Control amplification
reactions of a 503-bp fragment in the coding region the snow
leopard Transferrin Receptor (TfR) gene, using paired saliva (An;
lanes 2, 4 and 6) and blood samples (Bl; lanes 1, 3 and 5). The
negative amplification control with no DNA is shown in lane 7.
Figure 5 Validation of the E6 and E7 amplification products by
restriction enzyme digestion. (a) Top panel: Schematic
representation of the 694-bp E6 amplification product indicating the
positions of the two TaqI cleavage sites, and the sizes of the
resulting fragments (288, 279 and127 bp). Bottom panel: 50 ng of
genomic DNA isolated from two snow leopards (SL 1 and SL 3)
using the Oragene•ANIMAL kit were amplified using the E6 primer
pair. Half of each PCR reaction was incubated with the TaqI
restriction endonuclease. Restriction products (lanes 2 and 4), along
with an aliquot of the original PCR reactions (lanes 1 and 3) were
resolved by agarose gel electrophoresis and visualized by staining
with SYBR® Green. (b) Top panel: Schematic representation of 472-
bp E7 amplification product indicating the positions of the three
RsaI cleavage sites, and the sizes of the resulting restriction products
(263, 144, 36 and 29 bp). Bottom panel: 50 ng of genomic DNA
isolated from two snow leopards (SL 1 and SL 3) using the
Oragene•ANIMAL kit were amplified using the E7 primer pair. Half of
each PCR reaction was incubated with the TaqI restriction
endonuclease. Restriction products (lanes 2 and 4), along with an
aliquot of the original PCR reactions (lanes 1 and 3) were resolved
by agarose gel electrophoresis and visualized by staining with
SYBR® Green.
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obtained from the saliva of the two older snow leo-
pards (SL 1 and SL 3) produced a doublet correspond-
ing to the 288 and 279-bp fragments and a single 127-
bp fragment (Figure 5a, bottom panel, lanes 2 and 4).
Similarly, incubation of the E7 amplification products
from these animals with RsaI yielded two fragments of
the expected size (Figure 5b, bottom panels, lanes 2
and 4).
As an independent measure to confirm their identity,
we gel purified the E6 and E7 PCR products from the
two animals and subjected them to bi-directional DNA
sequencing. The sequencing results were assembled into
contigs and aligned to the consensus genome sequence
of UuPV1 (Figure 6). The multiple sequence alignment
in Figure 6 shows that the sequence of the E6 and E7
amplification products obtained from saliva is 100%
identical to the published UuPV1 genome sequence for
E6 and E7.
These two validation methods independently confirm
the identity of the E6 and E7 amplicons. Although
amplicon sequencing is preferable, it is can be more
expensive, time-consuming and requires significant
amounts of purified PCR products, which might not
always be feasible. In such cases, restriction digests pro-
vide an accurate, simple and cost-effective method to
rapidly screen even large numbers of samples. The
choice of two distinct validation methods in our assay
provides flexibility and makes it amenable to perform in
a variety of laboratory settings.
Discussion
We developed a molecular assay that detects papilloma-
virus DNA in snow leopard saliva. Our method is similar
to PCR-based molecular assays designed to detect different
types of human papillomavirus (HPV) in a variety of clini-
cal samples [21,23]. Specifically, presence of HPV-16 in
head and neck squamous cell carcinoma (HNSCC) biop-
sies is determined by amplification of the E6 and E7 genes
[21]. Similarly, E6 amplification is used to detect the pre-
sence of high-risk HPV subtypes in human cutaneous neo-
plasms and in cervical smears [23-25]. In some cases of PV
integration into host genetic material, E6 and E7 may be
the only genes that remain intact [20], thus making them
ideal choices for PCR-based detection of viral DNA.
The detection of UuPV1 DNA in the saliva of two
older snow leopards parallels results from HPV studies
that have demonstrated that HPV DNA can be ampli-
fied from oral rinses and saliva samples from HNSCC
patients and HIV positive individuals [10,26-28].
Because PVs are epitheliotropic, detection of PV DNA
in blood samples from infected snow leopards is unlikely
[18]; therefore, the absence of viral DNA in blood is
consistent with an expected PV replication pattern in
mucosal cells with no concurrent viremia.
The utilization of a PCR-based method to detect viral
DNA in saliva presents a number of advantages. First,
saliva collection is a non-invasive sampling method,
thereby circumventing the requirement for anesthesia
prior to obtaining a blood sample in captive wild felids.
This is particularly important for captive species that
are not routinely subjected to chemical restraint, and
may only be anesthetized for scheduled physical exams.
In these cases, saliva represents a more easily and fre-
quently accessible biological specimen than blood. An
additional advantage of testing saliva is that behavioral
modification techniques can be used to train snow leo-
pards and other felids to calmly accept an oral swab for
DNA collection without chemical restraint. In fact, we
were able to collect saliva samples from snow leopards
in their enclosure, with minimal disturbance to the ani-
mal. Subsequently, animals testing positive for viral
DNA can then be scheduled for a more thorough oral
examination under sedation. The use of saliva also
allows for detection of the virus in the anatomical site
where papillomatous lesions develop during later stages
of disease progression. Additionally, saliva is extremely
stable, and more easily preserved than serum samples,
thereby facilitating collection and shipping of samples
from different sites. In testing for HPV, it has been
demonstrated that PCR-based methods have increased
sensitivity as compared to serotesting [29], and can
accommodate even lower quality samples, such as archi-
val samples and paraffin-embedded specimens [23]. In
contrast to seropositivity which can indicate a present
and ongoing infection or a past infection that has been
cleared, a positive PCR test indicates a current infection
in the oral cavity of the animal. Therefore, PCR-based
testing of snow leopard saliva can complement serotest-
ing and help provide a more accurate picture of an ani-
mal’s disease status.
PCR-based detection of papillomavirus E6 and E7
DNA in the saliva of snow leopards may have utility in
diagnosing infection in animals that have no obvious
oral papillomatous lesions, confirming infection in cats
with oral papillomas, and detecting infection in animals
that have not yet seroconverted. Due to its non-invasive-
ness and ease of implementation, PCR-based testing of
saliva can be incorporated into the routine and regular
screening of captive snow leopards, which would greatly
facilitate the collection of epidemiological data on
UuPV1 infections. Additionally, since papillomatous
lesions have been reported to progress to SCC in snow
leopards [9,22], our assay can also be used to determine
whether viral DNA is present in biopsy samples of SCCs
to explore the relationship between UuPV1 infection
and neoplasia and elucidate the molecular mechanisms
underlying the development and progression of PV
induced disease.
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Figure 6 Sequence comparison of the E6 and E7 amplification products and UuPV1 genome. The E6 (SL1_E6 and SL3_E6) and E7 (SL1_E7
and SL3_E7) amplification products obtained from the saliva of two snow leopards were gel-purified and subjected to bi-directional Sanger
sequencing. The resulting sequences were aligned to the consensus UuPV1 genome (UuPV1, Genbank: DQ180494) using CLC Sequence Viewer
6. The sequences of the E6 and E7 genes in the UuPV1 genome are highlighted in cyan and the sequence length of each amplification product
is indicated. Ambiguous nucleotides in sequencing reactions are designated by Ns. Nucleotides that do not match the UuPV1 genome sequence
are highlighted in green.
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The finding that UuPV1 DNA is present in the saliva
of two adult snow leopards that have no current or
documented lesions is intriguing. The most likely expla-
nation for our finding is supported by the advanced age
of these animals and the fact that saliva was collected
following euthanasia due to progressive illness. Papillo-
maviruses can establish latent or low-level inapparent
infections, remaining undetected for long periods of
time [1], and these cats may have been experiencing
reactivation of a previously controlled PV infection. It is
also possible, although unlikely, that these animals had
recently become infected, and PV induced disease was
not manifested at the time of death.
One of the goals of conservation biology is to main-
tain genetically diverse captive populations of endan-
gered species. In relatively small populations, like the
150-200 captive snow leopards in North America, it is
critical to develop functional assays for assessing indivi-
dual differences in health and fitness. One such differ-
ence is an animal’s susceptibility to PV infection and to
the development of PV associated disease. In the current
study, we demonstrate that viral DNA is present in the
saliva of clinically normal animals. Therefore, our assay
can be used to classify clinically normal snow leopards
into PV-positive and PV-negative populations, which,
along with clinical data, can be studied to identify both
genetic and environmental factors underlying suscept-
ibility to viral infection and to the development and pro-
gression of disease. Similar studies in humans have
identified specific variants in immune genes as well as
in genes that interact with viral proteins and demon-
strated that these variants are associated with an indivi-
dual’s risk for viral persistence and with the subsequent
development of disease [30,31].
The conservation of endangered captive species
requires maintaining the genetic diversity of the popula-
tion. When captive populations suffer from inbreeding
depression, fitness decreases and mortality rates may
increase along with decreased reproductive success and
impaired immune function [32,33]. Genetic studies in
small populations of endangered species are challenging
because standard approaches like large-scale genetic
association studies are not possible. Instead, genetic
approaches must focus on individuals and place the
emphasis on developing effective means of characteriz-
ing phenotypes which can be used to study phenotypic
variation across the captive population. In the case of
the snow leopard, the well-documented infection of ani-
mals with papillomavirus [22] offers an opportunity to
develop robust phenotyping methods for assessing
immune function within the captive population. Unfor-
tunately, relatively little is known about snow leopard
susceptibility and resistance to papillomavirus infection
and disease progression. In order to better understand
the potential phenotypic variation underlying suscept-
ibility and resistance to viral infection, it is critical that
molecular tools be developed that can allow investiga-
tors to begin characterizing how phenotypes associated
with papilomavirus infection and disease progression
vary across closely and distantly related individuals. The
PCR assay we describe is a first step in this direction.
This assay can be used to (1) monitor the exposure of
individual snow leopards to papillomavirus, (2) accu-
rately identify which snow leopards are positive and
which are negative for papillomavirus, (3) characterize
the relationship between papillomavirus exposure and
the development of oral papillomatous lesions, (4) inves-
tigate the relationship between exposure and infection
when uninfected snow leopards are housed with infected
snow leopards and, (5) determine the timeline underly-
ing subclinical infection and presentation of clinical
signs. As more snow leopards participate in these stu-
dies, distributions describing these traits for the entire
captive population can be produced. Subsequently, indi-
viduals exhibiting phenotypes at the tails of the distribu-
tions can be identified and further studies aimed at
characterizing the genetic basis of snow leopard immu-
nity in captivity can be performed.
Conclusions
We developed a novel PCR strategy to detect papilloma-
virus in the snow leopard. Using this assay, we success-
fully amplified the E6 and E7 viral oncogenes in DNA
purified from saliva of two snow leopards. DNA sequen-
cing verified that the amplified fragments indeed repre-
sent the E6 and E7 genes of UuPV1. In addition, we
demonstrated that viral DNA cannot be detected in
paired blood samples from these animals, which is con-
sistent with the mechanism of papillomavirus infection
and viral lifecycle in the host. Taken together with the
non-invasiveness, and ease of collection relative to
blood, our results further underscore the utility of saliva
as a suitable clinical specimen for the detection of papil-
lomavirus in snow leopards. Our findings allow for the
development of a molecular tool to elucidate the
mechanisms underlying the development and progres-
sion of PV induced disease in this endangered species.
Methods
Sample collection and purification
We obtained paired saliva and blood samples from 3
captive snow leopards housed in North American zoos:
two female snow leopards that were approximately 18
years old, and a 7-week old female cub. None of these
animals had oral papillomatous lesions. We additionally
collected saliva samples from a 2-year old female and a
2-year old male snow leopard in their enclosures with-
out the use of anesthesia. Collection protocols were
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approved by the Western University Institutional Ani-
mal and Care Use Committee. Blood was drawn into
PAXgene Blood DNA tubes (Qiagen, Valencia, CA,
USA) and genomic DNA was isolated using the PAX-
gene Blood DNA kit (Qiagen, Valencia, CA, USA). Sal-
iva was collected using Oragene•ANIMAL kits (DNA
Genotek, Ontario, Canada) and DNA was purified from
the entire saliva sample using the manufacturer’s proto-
col [34]. All DNA samples were quantitated using a
Nanovue spectrophotometer (GE LifeSciences, Piscat-
away, NJ, USA). The purity of each DNA sample was
assessed using the A260/A280 ratio.
Primer design
The published UuPV1 genome sequence [Genbank:
DQ180494] was used to design PCR primers that
amplify DNA fragments encompassing the entire E6 and
E7 genes as shown in Figure 1(b). Primers were
designed using the freely available Primer3 software
package [35], and tested by In-silico PCR [36] to assess
whether they non-specifically amplify feline genomic




GGTTCGTCATCATCGCTACA-3’. The feline transfer-
rin receptor (TfR) mRNA sequence [Genbank:
NM_001009312] was used to design PCR primers that
amplify a 503-bp fragment in the coding region of the
gene. Primers were designed as described above and
used for cross-species amplification of the correspond-
ing region of the snow leopard transferrin receptor




DNA extracted from the 3 sets of matched saliva and
blood samples was used for amplification of the E6
and E7 genes of the snow leopard PV1. A 694-bp frag-
ment encompassing the E6 gene was amplified using
the E6-Forward and E6-Reverse primers. Reactions
were performed in a 50 microliter volume using 50 ng
genomic DNA, 0.2 μM each primer, 0.125 mM dNTPs,
1.5 mM MgCl2, 1X GeneAmp
® PCR Gold Buffer and
2.5 U Amplitaq Gold® DNA Polymerase (Applied Bio-
systems, Foster City, CA, USA) in a Veriti™ 96-well
thermal cycler (Applied Biosystems, Foster City, CA,
USA) using the following conditions: 95°C for 10 min,
10 cycles of 95°C 30 sec, 1 min annealing with a start-
ing temperature of 63°C decreasing by 0.5°C per cycle
down to 58.5°C and 72°C 1 min, followed by an addi-
tional 25 cycles of 95°C 30 sec, 58°C 1 min, 72°C 1
min and a final extension for 10 min at 72°C. A 472-
bp fragment encompassing the E7 gene was amplified
using the E7-Forward and E7-Reverse primers. Ampli-
fication reactions were performed in a 50 microliter
volume using 50 ng genomic DNA, 0.2 μM each pri-
mer, 0.125 mM dNTPs, 2.5 mM MgCl2, 1X Gen-
eAmp® PCR Gold Buffer and 2.5 U Amplitaq Gold®
DNA Polymerase (Applied Biosystems, Foster City,
CA, USA) in a Veriti™ 96-well thermal cycler (Applied
Biosystems, Foster City, CA, USA) using the following
conditions: 95°C for 10 min, 12 cycles of 95°C 30 sec,
1 min annealing with a starting temperature of 61°C
decreasing by 0.5°C per cycle down to 55.5°C and 72°C
1 min, followed by an additional 25 cycles of 95°C 30
sec, 55°C 1 min, 72°C 1 min and a final extension for
10 min at 72°C. 25 microliters of each PCR reaction
were resolved on a 1.5% agarose/1X TBE gel stained
with SYBR® Green (Invitrogen, Carlsbad, CA, USA).
All PCR reactions were repeated at least twice in inde-
pendent experiments.
A 503-bp fragment in the coding region of the snow
leopard transferrin receptor gene was amplified using
the TfR-Forward and TfR-Reverse primers. Reactions
were performed in a 50 microliter volume using 50 ng
genomic DNA, 0.4 μM each primer, 0.25 mM dNTPs,
2.5 mM MgCl2 and 2.5 U Taq DNA Polymerase (Qia-
gen, Valencia, CA, USA) in a Veriti™ 96-well thermal
cycler (Applied Biosystems, Foster City, CA, USA) using
the following conditions: 95°C for 10 min, 30 cycles of
95°C 30 sec, 54°C 1 min, 72°C 1 min and a final exten-
sion for 10 min at 72°C. 15 microliters of each PCR
reaction were resolved on a 1.5% agarose/1X TBE gel
stained with SYBR® Green (Invitrogen, Carlsbad, CA,
USA). All PCR reactions were repeated at least twice in
independent experiments.
Restriction analysis
The identity of the E6 and E7 amplification products
was validated by restriction enzyme digest. 25 microli-
ters of the E6 amplification products obtained from two
snow leopard saliva samples were incubated with 15 U
TaqI (Fermentas, Glen Burnie, MD, USA) in a 30
microliter reaction at 65°C for 2 hours. Digestion pro-
ducts were resolved on a 2.5% agarose/1X TBE gel
stained with SYBR® Green (Invitrogen, Carlsbad, CA,
USA). 25 microliters of each E7 amplification product
were digested with 15 U RsaI (Fermentas, Glen Burnie,
MD, USA) in a 30 microliter reaction at 37°C for 2
hours. Digestion products were resolved on a 2.5% agar-
ose/1X TBE gel with SYBR® Green (Invitrogen, Carls-
bad, CA, USA).
DNA sequencing
The E6 and E7 amplification products obtained from
two snow leopard saliva samples were purified using the
Mitsouras et al. BMC Veterinary Research 2011, 7:38
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Qiaex II Gel Extraction kit (Qiagen, Valencia, CA, USA)
and subjected to bi-directional DNA sequencing using
the E6 and E7 PCR primer pairs respectively. Sequen-
cing was performed at the UCLA Sequencing Core (Los
Angeles, CA, USA). The forward and reverse sequences
of each amplification product were assembled into a sin-
gle contig, and aligned to the consensus UuPV1 genome
sequence [Genbank: DQ180494] using the CLC
Sequence Viewer 6 software package (CLC Bio, Cam-
bridge, MA, USA).
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